Actualites Pharmaceutiques最新文献

{"title":"La transition écologique et sociale dans les études de pharmacie, un impératif pédagogique pour concilier qualité des soins et durabilité","authors":"Camille Savary (Maîtresse de conférences des universités en toxicologie),&nbsp;Clémentine Aubry (Maîtresse de conférences des universités en physique et chimie des matériaux),&nbsp;Simon Bordage (Maître de conférences des universités en pharmacognosie),&nbsp;Julien Marlet (Maître de conférences des universités-praticien hospitalier en sciences biologiques, fondamentales et cliniques),&nbsp;Nathalie Rude (Maîtresse de conférences des universités en biomathématiques et psychosociologie de la santé),&nbsp;Camille Schwab (Maîtresse de conférences des universités-praticien hospitalier en pharmacie clinique),&nbsp;Stéphanie SentiS (Maîtresse de conférences des universités en biochimie et cancérologie)","doi":"10.1016/j.actpha.2026.07.011","DOIUrl":"10.1016/j.actpha.2026.07.011","url":null,"abstract":"<div><div>Face à l’urgence climatique, à l’érosion de la biodiversité, aux pénuries de ressources et aux inégalités sociales, le ministère de l’Enseignement supérieur, de la Recherche et de l’Espace demande aux universités de former tous les étudiants de premier cycle à la transition écologique pour un développement durable. Les professionnels de santé doivent intégrer les enjeux de cette transition pour contribuer à l’atténuation de l’impact environnemental de leurs pratiques. Sensibiliser les étudiants à ces sujets est essentiel afin de former au mieux les futurs pharmaciens.</div></div><div>Face à l’urgence climatique, à l’érosion de la biodiversité, aux pénuries de ressources et aux inégalités sociales, le ministère de l’Enseignement supérieur, de la Recherche et de l’Espace demande aux universités de former tous les étudiants de premier cycle à la transition écologique pour un développement durable. Les professionnels de santé doivent intégrer les enjeux de cette transition pour contribuer à l’atténuation de l’impact environnemental de leurs pratiques. Sensibiliser les étudiants à ces sujets est essentiel afin de former au mieux les futurs pharmaciens.</div><div><div>In light of the climate emergency, the loss of biodiversity, resource shortages, and social inequalities, the Ministry of Higher Education, Research, and Space is calling on universities to educate all undergraduate students about the ecological transition toward sustainable development. Healthcare professionals must incorporate the challenges of this transition to help mitigate the environmental impact of their practices. Raising students’ awareness of these issues is essential to providing the best possible training for future pharmacists.</div></div><div>In light of the climate emergency, the loss of biodiversity, resource shortages, and social inequalities, the Ministry of Higher Education, Research, and Space is calling on universities to educate all undergraduate students about the ecological transition toward sustainable development. Healthcare professionals must incorporate the challenges of this transition to help mitigate the environmental impact of their practices. Raising students’ awareness of these issues is essential to providing the best possible training for future pharmacists.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 43-45"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Activité physique et sportive et pathologies cardiovasculaires","authors":"Peggy André (Docteure en pharmacie)","doi":"10.1016/j.actpha.2026.07.014","DOIUrl":"10.1016/j.actpha.2026.07.014","url":null,"abstract":"<div><div>L’activité physique et sportive est aujourd’hui reconnue scientifiquement comme une thérapeutique non médicamenteuse réduisant significativement l’incidence et des pathologies cardiovasculaires et la mortalité précoce associée. À l’officine, le pharmacien et son équipe peuvent encourager cette activité bénéfique.</div></div><div>L’activité physique et sportive est aujourd’hui reconnue scientifiquement comme une thérapeutique non médicamenteuse réduisant significativement l’incidence et des pathologies cardiovasculaires et la mortalité précoce associée. À l’officine, le pharmacien et son équipe peuvent encourager cette activité bénéfique.</div><div><div>Physical and sports activity is now scientifically recognized as a non-pharmacological treatment that significantly reduces the incidence of cardiovascular diseases and the associated premature mortality. At the pharmacy, the pharmacist and their team can encourage these beneficial activities.</div></div><div>Physical and sports activity is now scientifically recognized as a non-pharmacological treatment that significantly reduces the incidence of cardiovascular diseases and the associated premature mortality. At the pharmacy, the pharmacist and their team can encourage these beneficial activities.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 55-58"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Réforme du troisième cycle court, une ambition collective","authors":"Vincent Lisowski (Président de la Conférence des doyens des facultés de pharmacie, doyen de la faculté de pharmacie de Montpellier)","doi":"10.1016/j.actpha.2026.07.001","DOIUrl":"10.1016/j.actpha.2026.07.001","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Page 1"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Évaluez-vous !","authors":"Élisa Derrien (Rédactrice en chef)","doi":"10.1016/j.actpha.2026.07.016","DOIUrl":"10.1016/j.actpha.2026.07.016","url":null,"abstract":"<div><div>Ce QCM vous permet de vérifier les connaissances acquises à la lecture du numéro d’<em>Actualités pharmaceutiques</em>.</div></div><div>Ce QCM vous permet de vérifier les connaissances acquises à la lecture du numéro d’<em>Actualités pharmaceutiques</em>.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 62-64"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Les examens pharmaceutiques objectifs structurés, un outil clé de la réforme","authors":"Annie Standaert (PharmD, PhD maîtresse de conférences en parasitologie)","doi":"10.1016/j.actpha.2026.07.009","DOIUrl":"10.1016/j.actpha.2026.07.009","url":null,"abstract":"<div><div>La réforme du troisième cycle des études de pharmacie place l’évaluation des compétences des étudiants au cœur de la formation des pharmaciens d’officine. Les examens pharmaceutiques objectifs structurés permettent d’évaluer les étudiants à travers des mises en situation professionnelles simulées, au plus près des réalités officinales. Déployé à Lille depuis 2022, ce dispositif confirme que la compétence se construit autant sur le terrain qu’en faculté, soulignant le rôle clé de l’alternance dans le diplôme d’études spécialisées de pharmacie officinale.</div></div><div>La réforme du troisième cycle des études de pharmacie place l’évaluation des compétences des étudiants au cœur de la formation des pharmaciens d’officine. Les examens pharmaceutiques objectifs structurés permettent d’évaluer les étudiants à travers des mises en situation professionnelles simulées, au plus près des réalités officinales. Déployé à Lille depuis 2022, ce dispositif confirme que la compétence se construit autant sur le terrain qu’en faculté, soulignant le rôle clé de l’alternance dans le diplôme d’études spécialisées de pharmacie officinale.</div><div><div>The reform of postgraduate pharmacy studies places the assessment of students’ competencies at the heart of the training of community pharmacists. The OSPE enable students to be assessed through simulated professional scenarios that closely mirror the realities of pharmacy practice. Implemented in Lille since 2022, this approach confirms that competence is developed as much in the field as in the faculty, highlighting the key role of work-integrated learning within the certificate of advanced study in community pharmacy.</div></div><div>The reform of postgraduate pharmacy studies places the assessment of students’ competencies at the heart of the training of community pharmacists. The OSPE enable students to be assessed through simulated professional scenarios that closely mirror the realities of pharmacy practice. Implemented in Lille since 2022, this approach confirms that competence is developed as much in the field as in the faculty, highlighting the key role of work-integrated learning within the certificate of advanced study in community pharmacy.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 36-39"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"produits","authors":"","doi":"10.1016/j.actpha.2026.09.019","DOIUrl":"10.1016/j.actpha.2026.09.019","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 7-8"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"profession","authors":"","doi":"10.1016/j.actpha.2026.09.017","DOIUrl":"10.1016/j.actpha.2026.09.017","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 4-5"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"santé publique","authors":"","doi":"10.1016/j.actpha.2026.09.018","DOIUrl":"10.1016/j.actpha.2026.09.018","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Page 6"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Le némolizumab (Nemluvio®), nouvel anticorps monoclonal en dermatologie","authors":"Jacques Buxeraud (Professeur des universités),&nbsp;Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2026.07.002","DOIUrl":"10.1016/j.actpha.2026.07.002","url":null,"abstract":"<div><div>Le némolizumab (Nemluvio®) est un nouvel anticorps monoclonal utilisé sous forme injectable pour traiter la dermatite atopique et le prurigo nodulaire.</div></div><div>Le némolizumab (Nemluvio®) est un nouvel anticorps monoclonal utilisé sous forme injectable pour traiter la dermatite atopique et le prurigo nodulaire.</div><div><div>Nemolizumab (Nemluvio®) is a new monoclonal antibody administered by injection to treat atopic dermatitis and nodular prurigo.</div></div><div>Nemolizumab (Nemluvio®) is a new monoclonal antibody administered by injection to treat atopic dermatitis and nodular prurigo.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 10-11"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Une cascade œdémateuse","authors":"Théo Vincent (Docteur en pharmacie, doctorant en sciences pharmaceutiques)","doi":"10.1016/j.actpha.2026.07.004","DOIUrl":"10.1016/j.actpha.2026.07.004","url":null,"abstract":"<div><div>Les douleurs neuropathiques constituent un ensemble d’entités complexes, tant dans leur physiopathologie que dans leur symptomatologie et leur prise en charge. La gabapentine est une option de première intention pour de nombreuses douleurs de ce type, notamment grâce à son rapport bénéfice-risque favorable. Toutefois, son utilisation impose au pharmacien de vérifier plusieurs paramètres. Par exemple, la survenue d’œdèmes (périphériques ou généralisés) sous gabapentine doit faire évoquer une origine iatrogène.</div></div><div>Les douleurs neuropathiques constituent un ensemble d’entités complexes, tant dans leur physiopathologie que dans leur symptomatologie et leur prise en charge. La gabapentine est une option de première intention pour de nombreuses douleurs de ce type, notamment grâce à son rapport bénéfice-risque favorable. Toutefois, son utilisation impose au pharmacien de vérifier plusieurs paramètres. Par exemple, la survenue d’œdèmes (périphériques ou généralisés) sous gabapentine doit faire évoquer une origine iatrogène.</div><div><div>Neuropathic pain encompasses a range of complex conditions, both in terms of their pathophysiology and their symptoms and management. Gabapentin is a first-line treatment option for many types of neuropathic pain, particularly due to its favorable benefit-risk profile. However, its use requires the pharmacist to monitor several parameters. For example, the onset of edema (peripheral or generalized) while taking gabapentin should raise suspicion of an iatrogenic cause.</div></div><div>Neuropathic pain encompasses a range of complex conditions, both in terms of their pathophysiology and their symptoms and management. Gabapentin is a first-line treatment option for many types of neuropathic pain, particularly due to its favorable benefit-risk profile. However, its use requires the pharmacist to monitor several parameters. For example, the onset of edema (peripheral or generalized) while taking gabapentin should raise suspicion of an iatrogenic cause.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 659","pages":"Pages 15-19"},"PeriodicalIF":0.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149158514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}